This session covers key epidemiological considerations around the rising prevalence of frailty in todays and tomorrow’s population living with cardiovascular disease.

Factors driving rising frailty prevalence and onset in adult populations (which go way beyond just ageing alone)

Busting some common myths and unhelpful perceptions of frailty.

Challenges created by silo’d or single long term condition guidelines and the research evidence base.

The importance of recognising frailty as a long-term condition in its own right- which needs to take priority when present.

How to tailor and adapt our approaches to CVD prevention and management in persons living with frailty

Embracing 4 key high impact best practice principles to improve outcomes, reduce avoidable iatrogenic harms/adverse outcomes plus reduce inequalities and premature mortality risks to those living with frailty and CVD.

• 1.Understand why we must think Frailty first in the management of CVD for more fit for purpose and more successful Population Health Management
• 2.Understand the best way to identify and stage Frailty using Clinical Frailty scoring and the priority importance doing so to influence our management of cardiovascular disease.
• 3.Understand key best practice high impact principles around management -considering particularly importance of:
• a)Holistic assessment (using CGA framework)
• b)Avoiding common risks & harms from CVD medications and polypharmacy
• c)Personalisation and shared decision-making best practice.
• d)Proactive/Anticipatory Care